Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
MNKD
MNKD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest MNKD ETF News Today | Earnings, Events & Price Alerts
MNKD News
MannKind Reports 2025 Financial Results with Strong Sales Growth
4d ago
Benzinga
MannKind's Earnings Miss Expectations, Stock Drops
5d ago
Fool
MannKind Reports Mixed Earnings, Stock Drops Over 7%
5d ago
NASDAQ.COM
MannKind Corporation Reports Strong Q4 2025 Earnings and Growth Strategy
5d ago
seekingalpha
MannKind Shares Plummet to New 52-Week Low Following Earnings Miss
5d ago
seekingalpha
MannKind Q4 Earnings Beat Expectations with Revenue Growth
5d ago
seekingalpha
United Therapeutics' New Drug Plans Pressure Partner and Rival Stocks
6d ago
seekingalpha
MannKind Faces Uncertainty Over Tyvaso DPI Royalties
6d ago
stocktwits
MannKind to Announce Q4 Earnings on February 26
6d ago
seekingalpha
MannKind Launches Pediatric Diabetes Clinical Study for Afrezza
Feb 09 2026
Newsfilter
Longevity Infrastructure Market Undergoes Structural Reset
Jan 29 2026
PRnewswire
Global Capital Shifts to Longevity Infrastructure Valued at $27 Trillion
Jan 29 2026
Newsfilter
Avant Technologies Leads Transformation in Healthcare Market
Jan 26 2026
PRnewswire
Avant Technologies Leads Medical Innovation with Next-Gen Treatments
Jan 26 2026
Newsfilter
MannKind Receives FDA Approval for Afrezza Label Update
Jan 26 2026
NASDAQ.COM
MannKind's Afrezza Receives FDA Label Update Approval
Jan 26 2026
stocktwits
Show More News
